New scan could spot sarcomas more clearly, paving way for targeted treatment
NCT ID NCT06500065
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a special PET/CT scan using a tracer called 68Ga-DOTATATE can improve the detection of soft tissue sarcomas. About 30 adults with this cancer will receive the scan to see if it highlights tumors better than standard imaging. The goal is to determine if this method can help doctors decide on more personalized treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ohio State University Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43210, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive antibody light up hidden tumors?
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Could a massive tissue bank unlock sarcoma's secrets?
- Can a targeted pill stall advanced sarcomas?
- Protein-Wrapped chemo aims to hit tumors harder, spare healthy cells
- Drug duo takes on rare head and neck tumors